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Do a search on "drugs" and "history" and you would be rewarded by many titles. But many tread an all too familiar path. The The changes in drug policies in the period since the Second World War and in particular the 1960s and 1970s were significant and continue to excite debate in today's fluid situation. This review assesses three recent publications which throw light on that period, in very different ways. Musto and Korsmeyer cover the changes in US drug policy since the Johnson era in the 1960s up to the end of the Carter presidency in the 1970s. The collection of interviews edited by Griffith Edwards singles out some of the scientists, researchers and clinicians who collectively have 3Virginia Berridge, AIDS in the UK: the making ofpolicy, 1981 -1994 , Oxford University Press, 1996 4Carol Smart, 'Social policy and drug addiction:
a critical study of policy development', Br. J. Addiction, 1984, 79 (1): 3 1-9.
formed the "alcohol, drug and smoking field" over the past fifty years. Edwards' edited collection has one unifying idea-the post-Second World War evolution of a separate "field" of addiction specialists. It also provides, through its interview format, some of the raw material for other studies in drug, alcohol and smoking history. It is the second book to be published from the series ofAddiction interviews which the journal has featured for many years. The current collection has scientists from the USA and Canada. There are politicians and practitioner policy-makers from Australia; pioneers from the smoking field like Richard Doll and Charles Fletcher and the less well known Ove Ferno, the originator of nicotine replacement therapy. There are British drugs researchers; policy makers in the US; scientists in post-war Europe; community activists in the US, and researchers and policy-makers from Scandinavia. Each section finishes with a brief page or two overview from an expert in the field. With such a cornucopia it is impossible to do justice to every interview. Some overlap with Musto's study, for example an interview with Jaffe, and also one with Vincent Dole, the pioneer of methadone maintenance therapy in New York in the 1960s, although Musto's book appears not to have used this resource.
Can any general conclusions be drawn about the growth of the "field"? Interviewees from the 1950s talk of how small even the alcohol field was at that stage and how much it had grown by the time they left it. Everyone knew everyone, but later it was impossible to do that. The influx of refugees from Europe to America was a strong influence. Few, however, had the experiences of Charles Lieber, an expert on the biological aspects of alcohol abuse, who describes war-time displacement in Europe, beset by all the warring armies; this makes his later eminence all the more laudable. In the US, the Federal narcotics "farm" at Lexington, Kentucky, which provided both incarceration and treatment, was a formative influence for many researchers. International networks were important. Scientific meetings brought researchers together, as did the newly established WHO, and collaborative publication like the famous alcohol Purple Book of the 1970s forged a strong esprit de corps.6 Researchers from the Canadian Addiction Research Foundation, the powerhouse of research, treatment and prevention in that country since the 1940s, speak of the changes in research policy which have seen funded research give way to time limited grants, from "blue skies research" to direct policy and practice relevance. The Australians tell of policy battles, of more recent attempts to liberalize drug policy or of the failed attempt to institute a trial of heroin prescribing. The Scandinavians offer a window into a very different situation for research, with funding coming from the state alcohol monopoly-even for sociology. They outline the strong interest in Scandinavian co-operation, in research on policy, and a cadre of drug researchers who also maintain reputations in their general disciplinary fields.
There are vignettes which stand out. Here is Reg Smart of the Addiction Research Foundation speaking of E M Jellinek, the author of the seminal The disease concept of alcoholism: "Jellinek, as I remember him, was a short, sort of stooped-over, overweight man, with little hair left. Not at all a romantic figure, but he had married several times and he spoke often about his relationship with a Spanish ballet dancer, as well as his other romantic affairs. I remember him as a great rapporteur and teller of jokes. Ontario, 1975. times I saw people awaken him and ask him to summarize the discussion. Usually these summaries were very good" (p. 109).
The three interviews with characters of importance in the history ofpost-war British drug policy were of interest from my perspective. Spear had already produced a detailed paper on the evolution ofthe drug "problem" in the 1950s and 1960s which has been widely used by analysts of that period.7 In the book he takes that style of writing further, using mainly Home Office papers, and articles in the medical press from the time, as well as the review and reminiscence which has been published by others in the field over the last thirty years. Spear tells us how British drug policy evolved towards the "disaster" of the post Brain 2 period after 1965. Advice from the drugs inspectorate to the first Brain committee in the early 1960s was ignored and the committee produced a sanguine view of the rapidly deteriorating situation. The inspectorate's further warnings triggered the appointment of the second Brain committee, but the implementation of its conclusions was disastrous. The Ministry of Health delayed in setting up the promised treatment centres, obtaining its advice from "persons experienced in the treatment of addiction", the psychiatrists whom Spear obviously regarded with contempt. The Ministry, he argues, lost control of the situation to a clinical clique who excluded general practitioners and others experienced in the treatment of addiction. Changes in prescribing practice were carried through without liaising with the street agencies who knew the grass roots situation. At Bewley's clinic the change to time limited oral methadone prescribing was announced simply through a notice posted on the door. The subsequent medical attack on private prescribing in the 1980s arose out of the desire to impose clinical orthodoxy, which the private sector did not accept. This is a well known critique in the drugs field, which is here presented with some vigour and in detail. It is written as an historical analysis, 7 H B Spear, 'The growth of heroin addiction in the United Kingdom', Br. J. Addiction, 1969, 64: 245-55. but is a hybrid, a semi autobiographical account written by an important player in drug policy in the sixties with the intention of arguing the Home Office view and that of the inspectorate. It is valuable, but also frustrating. Alongside clinicians, women academics such as myself and Carol Smart were clearly particular irritants for Spear. The first chapter of his book, which deals with the period during and after the First World War, is framed as an attack on my own analysis of drug policy. This is the period of flux between 1916 and 1926, when clinicians and the Home Office negotiated the balance that was to operate in drug policy in the light of the requirements of intemational drug control. Was policy to be primarily penal in orientation, as in the US, or were medical men to be allowed to prescribe? These tensions established the medico-legal alliance which was to characterize drug policy for so long. I found this chapter, the vehemence and bias of its attack on myself, puzzling, in particular since our relations when Spear was alive had been cordial; he had never voiced these criticisms to my face. I related it to the general agenda of the book, which is to defend Spear's view of the Home Office and to criticize "psychiatric imperialism" in drug policy. Spear considered that my interpretation of the 1920s cast aspersions on the role of the Home Office and of Malcolm Delevingne, the civil servant who later became one of the "grand old men" of international drug control. He saw my analysis as making the medical profession the "heroes" and Delevingne the "villain". This is not the case, and I do not write history in the "heroes and villains" mode. The point I make is that the objectives of the Home Office changed over time. Delevingne came to realize that the role of the medical profession in the treatment of addiction had to be recognized. What resulted was a medico-penal alliance within which the balance of power could change to one side or the other. London, Athlone Press, 1996. comment from an interested perspective, as Spear does here. He writes as the Home Office inspector. By the 1960s and 1970s, his own period of key influence, the professions were relatively used to the requirements of control. In the 1920s, these were new systems which seemed to undermine professional freedom as well as being excessively bureaucratic. Spear's comments on the role of the Ministry of Health (p. 9) show that he is unaware of its history, that the Ministry was only recently established in the early 1920s. It did indeed have to win a position of influence in drug policy in contrast to the longer Home Office track record.
There is a further aspect to Spear's attack. At several points, he uses words selectively which appear to represent my views. He refers (p. 32) to a Home Office "defeat" as if this is my analysis and in order to criticize this interpretation of policy. The actual words I use present a different analysis. "In reality the outcome was more complex than a straightforward defeat for the Home Office. It was recognition that narcotic policy could not simply remain a matter of increasing state and police regulation, as had been the case since 1916. It was henceforward to be based on some form of partnership between the professional ideology of doctors and the aims of policy as seen from the Home Office."9 Spear's stance raises issues of source/historian relationships which are also of interest methodologically to those of us who work in the contemporary history field. The general topic is worth a fuller piece.
These books give a sense of the richness which awaits in the study of science and policy in the drugs, smoking and alcohol field in the last fifty years. Musto and Spear invite comparison between events in the US and those in the UK in those years as policy on both sides of the Atlantic moved closer together, aided by travel and interaction between key players. There are some striking similarities, despite the oft drawn contrast between the "liberalism" of British 9Virginia Berridge, 'Drugs and social policy: the establishment of drug control in Britain 1900 -1930 ', Br. J. Addiction, 1984 policy and the American "war on drugs". The role of doctor advisers-Connell and others in the UK, Boume and Jaffe in the US, is one parallel. The Federal location of drug policy in the States contrasts, however, with the departmental interests and empires which have characterized British drug policy. The role of the inspectorate in the UK also needs to be set within the context of inspectorial regimes in general. The books also raise questions of sources, methodology and interpretation. We can reinterpret the US policy history using Musto's document CD; Edwards' interviews await analysis; and Bing Spear's book provides source material for further study. Historical analysis does not deal in "true stories" or in "heroes and villains"; but these texts provide rich material for the considered national and cross national analysis which recent drug policy still needs.
